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Summary
The mechanisms underlying Zika virus (ZIKV)-related microcephaly and other neurodevelopment 
defects remain poorly understood. Here, we describe the derivation and characterization, including 
single-cell RNA-seq, of neocortical and spinal cord neuroepithelial stem (NES) cells to model 
early human neurodevelopment and ZIKV-related neuropathogenesis. By analyzing human NES 
cells, organotypic fetal brain slices and a ZIKV-infected micrencephalic brain, we show that ZIKV 
infects both neocortical and spinal NES cells and their fetal homolog, radial glial cells (RGCs), 
causing disrupted mitoses, supernumerary centrosomes, structural disorganization and cell death. 
ZIKV infection of NES cells and RGCs causes centrosomal depletion and mitochondrial 
sequestration of phospho-TBK1 during mitosis. We also found that nucleoside analogs inhibit 
ZIKV replication in NES cells, protecting them from ZIKV-induced pTBK1 relocalization and cell 
death. We established a model system of human neural stem cells to reveal cellular and molecular 
mechanisms underlying neurodevelopmental defects associated with ZIKV infection and its 
potential treatment.
INTRODUCTION
The human central nervous system (CNS) is a complex organ that, as a result of its extended 
development, is susceptible to a host of genetic and environmental insults. While great 
strides have been made in mapping the genetic landscape of human neurodevelopmental 
malformations, understanding of the mechanisms by which diverse environmental pathogens 
affect human neurodevelopment has been lagging (Bae et al., 2015; Diaz and Gleeson, 2009; 
Lui et al., 2011; Silbereis et al., 2016; Woods, 2004).
The emerging link between the mosquito-borne flavivirus Zika virus (ZIKV) infection of 
pregnant women and fetal microcephaly reinforces the need to use tissue- and species-
relevant cellular systems to study human CNS development and to establish experimental 
systems to model ZIKV infection, neurotropism, and treatment (Miner and Diamond, 2016; 
Schuler-Faccini et al., 2016a). In adults, rare complications of ZIKV infection include 
Guillain-Barré syndrome (Broutet et al., 2016; Oehler et al., 2014) and meningoencephalitis 
(Araujo et al., 2016). More prominently, ZIKV infection during pregnancy is associated 
with, and likely causative for, severe fetal abnormalities including microcephaly/
micrencephaly, lissencephaly, hydrocephaly, necrosis, periventricular and cortical 
calcifications, diffuse astrogliosis, hypoplasia of the brain stem and spinal cord, Wallerian 
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degeneration of the corticospinal tract and ocular abnormalities (Brasil et al., 2016; Mlakar 
et al., 2016; de Paula Freitas et al., 2016; Rubin et al., 2016). More broadly, the classical 
teratogenic TORCH syndrome pathogens [(T)oxoplasma, (O)ther agents, (R)ubella virus, 
(C)ytomegalovirus, and (H)erpes simplex virus] result in up to half of all perinatal deaths 
around the world, many associated with brain malformations including microcephaly, with 
an especially large burden in developing countries (Adams Waldorf and McAdams, 2013; 
Fine and Arndt, 1985).
Primary microcephaly mainly results from depletion of neural stem and progenitor cells due 
to centrosomal defects, premature differentiation, and/or cell death (Diaz and Gleeson, 2009; 
Woods, 2004). Recently, ZIKV was shown to preferentially infect human pluripotent stem 
cell (hPSC)-derived neural progenitors and organoids and cause cell death and mitotic 
impairment in ZIKV-mouse models (Dang et al., 2016; Garcez et al., 2016; Qian et al., 2016; 
Tang et al., 2016; Lazear et al., 2016; Li et al., 2016; Cugola et al., 2016; Miner et al., 2016; 
Wu et al., 2016). However, the human CNS is distinct in the diversity and proliferative 
potential of neural stem/progenitor cells (Lui et al., 2011; Bae et al., 2015; Silbereies et al., 
2016; Gage and Temple, 2013). As a result, there may be aspects of viral infection that are 
unique to the human brain. Moreover, to date there have been only limited reports on human 
cell-type specific responses to ZIKV over the course of infection, primarily in in vitro or 
murine model systems without comparison to infected human brain tissue. Finally, it is not 
known to what extent microcephaly results from direct ZIKV infection of developing neural 
cells versus indirect effects, such as inflammation and altered placental support, which has 
been shown to affect brain development (Burton and Fowden, 2015; Mor, 2016). Addressing 
these questions in the context of the developing human CNS is crucial for deciphering ZIKV 
tropism and neuropathogenesis.
Here, we describe the derivation and characterization of neocortical (NCX) and spinal cord 
(SC) neuroepithelial stem (NES) cells as in vitro models of neural stem/progenitor cells, 
early human neurodevelopment and ZIKV-related neuropathogenesis. NES cell lines are 
derived from primary neuroepithelial cells, the earliest population of resident neural stem 
cells present during neurodevelopment, when the neural tube is comprised of a 
pseudostratified neuroepithelium lining the central cavity (Bae et al., 2015). These cells 
constitute the ventricular zone (VZ) of the neural tube and serve as the stem cells of the 
CNS. Initially, neuroepithelial cells divide symmetrically to expand the stem cell pool 
(Silbereis et al., 2016). Later on, neuroepithelial cells transition into radial glia cells (RGCs) 
which reside in the VZ and the inner and outer subventricular zone (iSVZ and oSVZ). These 
cell populations serve as the stem or progenitor cells for neurons and macroglia (i.e. 
astrocytes and oligodendrocytes) and provide scaffolding for migrating nascent neurons (Bae 
et al., 2015). RGCs largely divide asymmetrically giving rise to either a daughter RGC, an 
intermediate progenitor cell (IPC), or a nascent neuron that subsequently migrates. Because 
of the ability to self-renew and differentiate, neuroepithelial cells are ideal candidates for 
studies of neural stem cell biology and various developmental diseases.
By comparing NES cells, organotypic fetal brain slices and the postmortem human tissue in 
the context of ZIKV infection, we show that ZIKV infects both NCX- and SC-NES cells and 
their fetal homolog, RGCs in the VZ and SVZ, and to a lesser extent, postmigratory neurons 
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in the cortical plate (CP; anlage of the cerebral cortical layers 2–6). ZIKV infection was 
associated with mitotic impairment, structural disorganization of the proliferative zones and 
increased cell death of NES cells and RGCs. We also found that ZIKV causes subcellular 
relocation of the phosphorylated TANK-binding kinase 1 (pTBK1), a pivotal player in 
antiviral innate immunity and cell proliferation (Farlik et al., 2012; Helgason et al., 2013; 
Pillai et al., 2015; Thurston et al., 2009), from centrosomes to mitochondria during mitosis 
of NES cells and RGCs. Antiviral nucleoside analogs, including the FDA-approved drug 
Sofosbuvir, inhibited ZIKV replication and ZIKV-induced cytopathology in NES cells. 
Together, these results validate the use of this NES cell system as an experimental model for 
studying early human neurodevelopment and ZIKV-induced pathogenesis, provide a testable 
hypothesis for the mechanism of ZIKV-induced cytopathology and lay the groundwork for 
future research on ZIKV-related neurodevelopmental defects and therapy.
RESULTS
Derivation of Human Neocortical and Spinal Cord Neuroepithelial Stem Cells
Different early human neural stem/progenitor cell types, including neuroepithelial-like cells, 
have been derived from hPSCs and the developing human brain (Conti and Cattaneo, 2010; 
Edri et al., 2015; Elkabetz et al., 2008; Sun et al., 2008, Tailor et al., 2013). However, to the 
best of our knowledge, stable cell lines of neuroepithelial cells have not been derived from 
the dorsal forebrain (prospective NCX) or the SC. Thus, we attempted to generate stable 
long-term, self-renewing populations of NCX and SC neuroepithelial cells from 10 human 
specimens ranging from 5 to 8 pcw (Carnegie stage 15–17) (Figure 1A and Table S1).
Dissociated cells were plated and examined for the presence of neural rosettes reminiscent 
of the radial arrangement and apico-basal polarization established by neuroepithelial cells in 
the native neural tube (Figure 1B). In total, we derived and characterized 5 stable NCX and 3 
stable SC neuroepithelial cell lines. Moreover, after propagation in the presence of the 
growth factors FGF2 and EGF, as well as BDNF (Figure S1A and S1J), the neuroepithelial 
cell lines exhibited stem/progenitor cell characteristics and retained a high neurogenic 
capacity; thus we termed them NCX- and SC-NES cells, respectively. Both NCX- and SC-
NES cells were immunopositive for the neuroepithelial marker SOX1 and the pan-neural 
stem cell markers nestin, SOX2 and vimentin (VIM) (Figure 1C, 1D, S1B and S1K). 
Metaphase NES cells were also observed, labeled with the anti-phospho-VIM antibody, and 
some of them displayed a typical basal process (Figure S1C).
Next, we investigated whether NES cells retained regional identity after long-term 
expansion. NCX-NES cells expressed FOXG1 and OTX2 (Figure 1E and Figure S1D), key 
transcription factors demarcating proliferative zones of the early human forebrain (Onorati et 
al., 2014). On the other hand, SC-NES cells were positive for the caudal regional marker 
HOXB4 (Krumlauf et al., 1993) (Figure S1L), thus demonstrating maintenance of regional 
identity even after more than 10 passages. These cell lines have been expanded for more 
than one year and 35 passages with no evidence of chromosomal instability (Figure S1E and 
S1M).
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To test the neurogenic potential of NES cells, we used an optimized differentiation protocol 
(Figure S1F). All NES cells gave rise to MAP2+ and TUBB3+ neurons and extended 
neurites (Figure S1G and S1H). We found that NCX-NES cells differentiated into neurons 
positive for BCL11B (also known as CTIP2), a marker of deep layer excitatory projection 
neurons in the NCX (Figure S1H). SC-NES cells also gave rise to TUBB3-, MAP2- and 
RBFOX3 (also known as NeuN)-positive neurons, while some exhibited a cholinergic 
phenotype, as expected for a spinal cord neuronal population (Figure S1N and S1O). 
Furthermore, GFAP+ astroglial cells (Figure S1I and S1P) and occasional O4+ 
oligodendrocytes were detected (Figure S1Q), thus demonstrating the multipotential stem 
cell capacity of NES cells.
Human NES Cells Exhibit the Transcriptional Signature of Early Neural Stem Cells
To further characterize NCX-NES cells, we conducted single-cell RNA-seq on 439 
expanded NCX-NES cells and 383 cells from 5–6 and 8 pcw donor-matched NCX (Table S1 
and Table S2); 362 and 255 cells, respectively, passed our quality-control pipeline 
(Supplemental Experimental Procedures). The majority of cells analyzed from the donor-
matched NCX tissue samples expressed canonical marker genes for neuroepithelial cells and 
RGCs of the dorsal forebrain (Figure 1F). NCX-NES cells showed similar expression 
profiles as their donor-matched NCX cells (Figure 1F). Neither brain NCX cells nor NCX-
NES cells expressed ventral forebrain markers (Figure 1G and Figure S2D).
To place the transcriptional profiles of NCX-NES cells within the context of fetal 
development, we supplemented our donor-matched datasets with single-cell RNA-seq data 
from 526 cells collected from fetal NCX at 16, 19 and 20 pcw (Figure 1H); 392 of them 
cells passed quality control. We conducted principal component analysis for dimension 
reduction with genes as observations and single cells as variables (Figure S2A). The first 
principal component was used as the representation of each fetal time point or NCX-NES 
cell line. Pairwise Pearson’s correlation test was showed that NCX-NES cells highly 
correlated with embryonic development time points (r>0.8; Figure S2B). We next applied a 
clustering algorithm designed for single-cell studies, SNN-Cliq, to explore cellular 
composition over neocortical development and in NCX-NES cells. Based on the expression 
of marker genes for various cell types, we identified five NCX clusters (Figure S2C) 
representing ventricular and outer RGCs (vRGCs and oRGCs, respectively), two types of 
IPCs, and early neurons (Figure 1I). As expected from the expression profiles of NCX-NES 
cells, the largest of the three NCX-NES cell clusters highly correlated with the vRGC and 
IPC clusters, while the other two NCX-NES cell clusters showed neuroprogenitor-like gene 
expression profiles (Figure S2D). Together, these data establish NCX- and SC-NES cell 
lines as relevant models of early human CNS development.
Human NES Cells, but not NES-derived Neurons, can be Efficiently Infected by ZIKV
We sought to test whether the NCX-NES cell system can be used as a model for ZIKV 
infection. First, we infected NCX-NES cells with the 2010 Cambodian ZIKV strain FSS 
13025 (multiplicity [MOI] = 0.1), which shares 98% nucleotide identity with the current 
Brazilian epidemic strain. We monitored NCX-NES cells up to 6.5 days post-infection 
(DPI). At DPI 3.5 we observed widespread ZIKV infection, as demonstrated by 
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immunolabeling for the viral nonstructural protein 1 (NS1), with over 90% of NCX-NES 
cells infected (Figure S3A and Figure S4F). We also observed a significant decrease in cell 
density over time, compared to mock-infected cells (Figure S3B). Notably, the number of 
active caspase 3 (aCASP3+) apoptotic cells, as well as of pyknotic cells (i.e. cells showing 
condensation of the chromatin), was significantly higher in the infected group at DPI 3.5 and 
6.5, compared to mock control (Figure S3C and S3D). Based on the analysis of 
immunolabeling for MKI67 (also known as Ki-67), a static marker of proliferative activity, 
we found that the proliferation levels were also significantly decreased by DPI 3.5, with a 
continued decline through DPI 6.5 (Figure S3E and S3F). Electron microscopy also showed 
viral particles in infected NCX-NES cells and signs of nuclear fragmentation, compared to 
mock cells (Figure 1J and 1K).
Recent studies have shown that hPSC-derived and mouse neural progenitors and neurons are 
infected by ZIKV, though neural stem/progenitor cells are preferential targets of infection 
(Qian et al., 2016; Tang et al., 2016). To test this in our model system, ZIKV was used to 
infect NCX-NES cells after differentiating them into neurons for 48 days. At DPI 3.5, no 
obvious increase in the cytopathic effect or cell death was evident in the ZIKV-treated 
cultures (Figure S4A and S4B). In order to discriminate between ZIKV infection of neurons, 
which are postmitotic and express high levels of MAP2, and progenitors, we administered 5-
bromo-2’-deoxyuridine (BrdU), a thymidine analog that incorporates into newly synthesized 
DNA, before ZIKV infection (Figure S4C). We found that only ~7.2% of the cells in the 
neuronal cultures were NS1+ (Figure S4D, S4E and S4F). Among the NS1+ neurons, 46% 
were BrdU−, thus indicating that only ~3.3% of postmitotic neurons were infected by ZIKV 
(Figure S4G, S4H and S4I). Therefore, the ability of ZIKV to infect neurons is extremely 
low in comparison to its ability to infect self-renewing NES cells (~90%, Figure S4F). This 
result also suggests that some NES cells infected during mitosis could have passed the 
infection onto daughter cells destined to become neurons.
ZIKV Preferentially Infects RGCs Causing Scaffold Disorganization in Fetal Organotypic 
Slices
In addition to NES cells, we also infected ex vivo human organotypic fetal brain slices with 
ZIKV strain FSS 13025 (Figure 2A and Table S3). Before infection, brain slice cultures 
showed completely normal anatomical structures of the developing NCX, including an intact 
VZ/SVZ, intermediate zone/subplate (IZ/SP) and CP, with a prominent RG scaffold (Figure 
2B). At DPI 1.5, only a few cells were infected and nearly all infected cells resided in the 
VZ/SVZ (Figure 2C); no obvious anatomical or cellular defects were otherwise observed. 
Interestingly, we did not observe any postmigratory neurons in the CP that were NS1+ at 
DPI 1.5 (Figure 2C). A dramatic increase in the number of NS1+ cells was evident at DPI 
3.5 and 6.5, mostly located in the VZ, SVZ and IZ/SP (Figure 2F and 2G). A majority of 
NS1-expressing cells also stained positive for the RGC marker VIM (Figure 2C, 2F and 2G). 
Immunostaining of VIM showed that the RG scaffold was disorganized and the radial 
organization of neurons in the CP was altered adjacent to highly infected regions of brain 
slices as compared to less infected regions or uninfected control (Figure 2D, 2E, 2F and 2G). 
By DPI 6.5, architectural disorganization was even more pronounced, with non-infected 
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VIM+ RGCs acquiring a “balloon” shape, suggesting an indirect, non-cell autonomous effect 
of ZIKV-infected cells (Figure 2F and 2G).
To test whether ZIKV-induced effects are virus strain-specific, we tested the neurotropism of 
a Brazilian ZIKV strain, PE243, on NES cells, revealing an extensive NS1-positivity at DPI 
3.5 (Figure S5A), which was not present in mock-infected cells or cells exposed to UV- or 
low pH-inactivated ZIKV particles. ZIKV PE243 also infected a neural primary culture from 
a 15 pcw NCX tissue, with widespread NS1+ signal (Figure S5B). ZIKV PE243-infected 
organotypic brain slices also exhibited an architectural disorganization of the RG scaffold at 
DPI 3.5. (Figure S5C).
Neocortical RGCs Contain ZIKV in an Infected Human Microcephalic Fetus
To confirm that ZIKV infection of RGCs is linked with microcephaly/micrencephaly, we 
examined postmortem forebrain and spinal cord tissues of the first reported ZIKV-infected 
microcephalic fetus (approximately 30 pcw, Table S4) from a ZIKV-infected mother (Mlakar 
et al., 2016) (Figure 3A). ZIKV RNA was previously found in the brain tissue of this fetus 
by RT-PCR (Mlakar et al., 2016). Tissue sections of the forebrain were immunopositive for 
NS1 and the ZIKV envelope (E) glycoprotein in the neocortical VZ and SVZ RGCs (Figure 
3B–E), which were identified by their position, morphology and the expression of VIM 
(Figure 3G and I). Regions of the neocortical VZ/SVZ and RG morphology in those regions 
were disorganized in the infected brain, with numerous ventricular protrusions and a visually 
apparent decrease in the density of basal processes from RGCs as compared to an age-
matched postmortem control (Figure 3F and H). RGCs also clustered abnormally in the 
VZ/SVZ and the RG scaffold was disorganized, particularly in aCASP3+ cells, as indicated 
by nestin or VIM staining (Figure 3I, L and M). Neurons in the NCX appeared disorganized 
and dysplastic, which could be due to either direct infection by ZIKV or indirectly through 
altered migration and neuron placement resulting from disruptions to the RG scaffold 
(Figure 3J). We did not observe infected cells in the ependymal layer, derivatives of RGCs 
lining the central canal of the spinal cord (Figure 3K).
NES Cells and RGCs Express the Putative ZIKV Entry Receptors AXL and TYRO3
To better understand why ZIKV preferentially infects neural stem cells and RGCs, we 
surveyed the expression of putative ZIKV entry receptors in the NCX-NES cells and human 
fetal brain. Recent studies suggested that a number of cell surface proteins may serve as 
ZIKV entry factors, including AXL, TYRO3, CD209, HAVCR1, and TIMD4, with AXL 
being the most plausible candidate (Hamel et al., 2015; Nowakowski et al., 2016). Among 
these five putative receptors, single-cell RNA-seq analysis found that AXL was generally 
expressed at the highest and most consistent levels in NCX-NES cells and RGCs/IPCs from 
the developing NCX (Figure 4A) while TYRO3 was expressed inconsistently and other 
receptors were essentially not expressed by NES cells, RGCs, and IPCs (Figure 4A and 
S2D). Analysis of previously published adult single-cell sequencing data (Darmanis et al., 
2015) indicated that AXL was highly expressed in adult astrocytes, microglia, and 
endothelial cells, but not in neurons (Figure 4B and S6A). Analysis of tissue-level 
transcriptome data from the developing human brain (Kang et al., 2011) showed that both 
AXL and TYRO3 expression in the NCX have bimodal patterns, with high expression in 
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embryonic and early fetal samples, and again increased expression beginning during late 
fetal development that remains at elevated levels after birth until adulthood (Figure 4C and 
4D), this being consistent with the pattern of astrocyte generation (Zhang et al., 2015).
We corroborated the transcriptional data through immunofluorescence analysis of AXL 
protein expression and found co-expression of AXL and VIM in NCX-NES cells (Figure 4E 
and 4F). AXL expression in 14 pcw NCX was detected in VZ and VIM+ RGC basal 
processes, as well as in blood vessels (Figure 4G). AXL was highly expressed in the 
VZ/SVZ but not in the CP of fetal organotypic slice cultures (Figure 4H). Interestingly, NS1 
staining was close to AXL staining in infected organotypic slices (Figure 4H). AXL signal 
was scarcely detectable in adult neocortical astrocytes, restricted to their end-feet contacting 
blood vessels, and in the periventricular astrocyte ribbon (Figure 4I). Taken together, these 
observations support AXL, and possibly TYRO3, as viral entry factors and may explain the 
cell-type specificity of ZIKV infection in NES cells and RGCs (Nowakowski et al., 2016).
ZIKV Infection Redirects pTBK1 from Cytoplasm and Centrosomes to Mitochondria During 
Mitosis
Recent work reported that ZIKV disrupts mitosis and increases cell death in neural stem 
cells (Garcez et al., 2016; Qian et al., 2016), although the molecular basis of these effects is 
unknown. TANK-binding kinase 1 (TBK1) is a cellular serine-threonine kinase that is 
essential for both innate antiviral immune signaling and for cell proliferation, as well as 
other processes (Farlik et al., 2012; Helgason et al., 2013; Pillai et al., 2015; Thurston et al., 
2009). We hypothesized that ZIKV could disrupt NES cell proliferation by diverting TBK1 
activity away from mitosis and toward innate immune signaling. By using single-cell RNA-
seq data, we found that TBK1 was highly expressed in both NES cells and RGCs/IPCs in the 
fetal NCX, but not in immature neurons (Figure 5A). Single-cell RNA-seq data also showed 
that TBK1 is highly expressed in neurons, astrocytes and microglia in the adult brain (Figure 
5A). Consistent with this expression, analysis of a developing human brain transcriptome 
data set (Kang et al., 2011) revealed a bimodal pattern of TBK1 expression in the NCX, with 
high expression in the embryonic and early fetal samples and again during postnatal 
development (Figure S6B).
To investigate if TBK1 levels changed during ZIKV infection, we conducted droplet digital 
PCR (ddPCR) on both ZIKV-infected and mock-infected NES cells and organotypic brain 
slices. No differences in TBK1 levels were found between uninfected and ZIKV-infected 
(with either the Cambodian or Brazilian ZIKV strains) NES cells or organotypic slices, 
though expression of TBK1 in the homogeneous NES cell population was greater than in the 
organotypic brain slices, which are composed of both neural stem/progenitor cells and 
immature postmitotic neurons (Figure 5B). This indicates that ZIKV infection does not lead 
to obvious changes in TBK1 mRNA expression in our two model systems. We therefore 
surveyed protein expression by immunoblotting for TBK1 and phosphorylated TBK1 
(pTBK1) on human tissue from fetal VZ/SVZ and CP and found that there was a higher 
level of pTBK1 in VZ/SVZ compared to CP (Figure 5C). Furthermore, immunofluorescence 
revealed that phospho-VIM+ mitotic NES cells co-expressed pTBK1 in centrosomes and 
midbody (Figure 5D). Consistent with this, pTBK1+ cells co-expressed PAX6 in the VZ/
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oSVZ of the fetal neocortical wall (Figure 5D). Together, these results suggest that ZIKV 
affects the localization or activity of TBK1 without substantially altering TBK1 expression.
We therefore examined the localization of pTBK1 in NCX-NES cells and organotypic slices 
during ZIKV infection. We found that pTBK1 localized to the centrosomes in NCX-NES 
cells and RGCs of organotypic brain slices, as demonstrated by co-staining of pTBK1 and 
TUBG (also known as γ-tubulin) (Figure 5E, 5G, 5K and 5M). In contrast, pTBK1 was no 
longer detected in centrosomes in ZIKV-infected cells, but instead localized to mitochondria, 
as shown by colocalization with ATP5A1 (Figure 5F, 5H, 5L, 5N and 5O). Relocalization of 
pTBK1 to mitochondria in ZIKV-infected NES cells was confirmed by immunoelectron 
microscopy (Figure 5I and 5J). ZIKV-infected cells also exhibited disrupted mitotic 
progression, including an increase in the number of NES cells and RGCs containing more 
than two centrosomes (Figure 5H, 5N and 5P). Mitochondrial shape also appeared different 
as shown by electron microscopy, with increased mitochondrial area in ZIKV-infected NES 
cells, while mitochondrial density was unchanged (Figure 5Q).
TBK1 Inhibitors Impair Mitosis, Provoke Supernumerary Centrosomes in NES cells, and 
Exacerbate ZIKV-Related NES Cell Death
Given that the enrichment of pTBK1 at centrosomes of mitotic NES cells and RGCs is 
altered by ZIKV infection and that TBK1 has been functionally linked to mitosis (Pillai et 
al., 2015), we asked whether pharmacological inhibition of TBK1 kinase activity could 
mimic the impairment caused by ZIKV infection. We therefore treated NCX-NES cells with 
a small-molecule inhibitor of TBK1/IKKε, Amlexanox, which inhibits TBK1 activity but 
not its phosphorylation on Ser172 (Reilly et al., 2013). We found that Amlexanox caused a 
significant decrease in the number of pTBK1+ mitotic cells and increased the number of 
cells exhibiting supernumerary centrosomes 3.5 days after application (Figure 5R and 5S). 
Similar effects were demonstrated by another TBK1 inhibitor, BX795 (Figure 5R and 5S). 
These results are consistent with our previous finding that ZIKV-induced pTBK1 
relocalization correlates with the neurodevelopmental pathology seen in the infected human 
brain.
TBK1 also instructs autophagy and apoptosis (Helgason et al., 2013). Therefore, inhibition 
of TBK1 may protect cells from cell death. We next investigated whether inhibiting TBK1 
kinase activity impacts ZIKV-induced death of NCX-NES cells at DPI 3.5. Application of 
Amlexanox or BX795 had no effect on cell death of uninfected cells (Figure S7A and S7B). 
However, both inhibitors modestly but significantly increased apoptotic cell death in ZIKV-
infected NCX-NES cells (Figure S7A and S7B). Next, we also tested whether the two 
inhibitors can affect cell death in ZIKV-infected SC-NES cells at DPI 3.5. Surprisingly, 
Amlexanox modestly decreased aCASP3+ while BX795 had no effect at DPI 3.5 (Figure 
S7C). We tested the effect of Amlexanox at DPI 5.5 and found that it increased aCASP3+ in 
SC-NES cells as observed in NCX-NES cells at DPI 3.5 (Figure S7E and S7F). Together, 
these results suggest that inhibition of TBK1 kinase activity can lead to severe cellular 
defects in mitotic NES cells and thus may exacerbate ZIKV-related cytopathology.
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Relocalization of pTBK1 by Other Viruses and Innate Immune Stimulation
Since TBK1 activation is an important component of innate antiviral signaling, we examined 
whether infection with another flavivirus, dengue-2 virus (DENV), or with another TORCH 
pathogen, human cytomegalovirus (HCMV), could induce similar relocalization of pTBK1. 
Both DENV and HCMV infected NES cell cultures (Figure 6A and 6B), but had different 
effects on pTBK1 localization. While HCMV also induced mitochondrial targeting of 
pTBK1, DENV did not (Figure 6A and 6B). This could be because DENV is known to 
inhibit the transduction of cytosolic RIG-I-like receptor (RLR) signaling through 
mitochondrial antiviral signaling (MAVS) and TBK1 to initiate cellular innate antiviral 
programs (Dalrymple, Cimica and Mackow, 2015; He et al., 2016). Nevertheless, both 
DENV and HCMV induced cell death via CASP3 activation (Figure 6C). These data show 
that TBK1 activation and mitochondrial localization of pTBK1 is not specific to ZIKV.
To determine whether RLR activation alone can induce the relocalization of pTBK1 from 
centrosomes to mitochondria, we treated NES cells with KIN1408, a small molecule agonist 
of RLRs (Pattabhi et al., 2016). Indeed, KIN1408 treatment induced relocalization of 
pTBK1 from centrosomes to mitochondria (Figure 6D and 6E) and increased CASP3-
mediated cell death (Figure 6D and 6F). Together, these data suggest that ZIKV may activate 
RLRs, causing relocalization of pTBK1 from mitotic centrosomes to mitochondria, 
disruption of mitosis, and induction of cell death.
Nucleoside and Nucleotide Analogs Inhibit ZIKV Replication and Protect NES Cells
There is an urgent need to identify therapeutic approaches to halt ZIKV infection, especially 
in pregnant women (Barrows et al., 2016). Chain-terminating nucleoside analogs have 
proven to be potent, broad-spectrum antivirals. Indeed, a few nucleoside analogs have 
already been shown to inhibit ZIKV in cell culture and mouse models of infection (Zmurko 
et al., 2016; Eyer et al., 2016), although the antiviral activity, pharmacology, and toxicity of 
these specific molecules in humans are unknown. We therefore examined whether 
nucleoside analogs that show potent inhibition of hepatitis C virus (HCV), another member 
of the Flaviviridae, could inhibit ZIKV infection in NES cell cultures. An initial screen of 
several HCV inhibitors in Huh-7 hepatoma cells revealed that the nucleoside analog 2´-C-
methyladenosine and the nucleotidyl prodrug Sofosbuvir showed antiviral activity against 
ZIKV, whereas Mericitabine, Balapiravir, PSI-6206, and 4′-azidocytidine analogs HY-77651 
and HY-77652, lacked ZIKV antiviral activity (not shown). Importantly, 2´-C-
methyladenosine and Sofosbuvir both had potent anti-ZIKV activity in NES cells (Figure 7A 
and 7B). Sofosbuvir protected NES cells from ZIKV-induced cell death, while 2´-C-
methyladenosine exhibited mild toxicity on its own (Figure 7A and 7C). Furthermore, both 
compounds inhibited the relocalization of pTBK1 (Figure 7D). Together, these data suggest 
that Sofosbuvir, a drug approved for treatment of chronic HCV, shows promise in protecting 
neural stem cells from ZIKV infection and pathogenesis.
DISCUSSION
The increased incidence of microcephaly linked to maternal ZIKV infection has created an 
international public health crisis. Understanding ZIKV cell tropism, the impact of ZIKV on 
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cell biology, and how these effects lead to microcephaly and other neurodevelopmental 
phenotypes requires either direct access to developmental human brain tissue or the 
development of suitable model systems. In this study, we present several key advances. First, 
we report on the derivation and characterization of NES cells, a novel model system of long-
term neuroepithelial stem cells derived from the NCX or the spinal cord. We also show that 
NES cells and RGCs are infected, mitotically impaired, and killed by ZIKV. We describe the 
relocation and sequestration of pTBK1 from centrosomes to mitochondria following ZIKV 
infection. Furthermore, we show that inhibition of TBK1 phenocopies ZIKV infection-
associated mitotic defects and supernumerary centrosomes. Finally, we found that two 
nucleoside analogs, one of which is an approved drug, can inhibit ZIKV replication and cell 
death in NES cells. These results are consistent with, and substantially add to, recent studies 
on ZIKV neurotropism and potential entry receptors (Miner and Diamond, 2016).
Several neurogenic populations of stem/progenitor cells have been developed from mouse or 
human neural tissue, but many of these culture systems have limited neurogenic and 
differentiation potentials (Onorati et al., 2011; Sun et al., 2008). While recent work on 
hPSCs has expanded the range of neural cell types attainable (Conti and Cattaneo, 2010; 
Edri et al., 2015; Koch et al., 2009), and a population of NES cells has been derived from the 
hindbrain (Tailor et al., 2013), the NES cell system we described and characterized is, to our 
knowledge, the first neuropotent populations derived directly from the prospective NCX and 
spinal cord, respectively. As such, NES cells represent a substantial advance facilitating the 
study of early development and neuropathology in the human CNS. Additionally, by 
conducting a comprehensive single-cell RNA-seq analysis of NES cells and human prenatal 
NCX specimens, including matched donor tissue, we have also generated a resource for 
future neuroscience and genomic studies.
By comparing our NES cells to ex vivo fetal organotypic brain slices and a ZIKV-infected 
fetal brain, we demonstrated definitively that RGCs are the primary cell type infected by 
ZIKV in the prenatal human brain, as previously suggested by using hPSC-derived neural 
progenitors or midfetal stem cell systems (Dang et al., 2016; Garcez et al., 2016; Qian et al., 
2016; Tang et al., 2016; Lazear et al., 2016; Li et al., 2016; Cugola et al., 2016; Miner et al., 
2016; Wu et al., 2016; Hanners et al., 2016; http://www.biorxiv.org/content/biorxiv/early/
2016/06/15/058883.1.full.pdf). We also found that early spinal cord stem cells can be 
infected by ZIKV. This is in agreement with a previous report showing spinal cord defects in 
ZIKV–infected mouse models (Lazear et al., 2016) as well as a human case where 
descending tracts of the spinal cord, particularly the lateral corticospinal tracts, were very 
affected (Mlakar et al., 2016), though this latter phenotype could be a secondary 
consequence of cortical infection. Why ZIKV infection is associated with micrencephaly, 
rather than spinal cord defects, may in part be a result of the timing at which infection 
happens; human spinal cord completes neurogenesis much earlier than the rest of the CNS 
(Silbereis et al., 2016), and so if infection occurs after the end of the first trimester, spinal 
cord cells may rarely be infected. However, the low percentage of neurons infected in NES 
cells and the fact that infected neurons in the organotypic slice cultures appeared only after 
the infection of VZ/SVZ RGCs suggest that some neurons may inherit the virus from 
infected RGCs. We found that ZIKV infection of NES cells and RGCs caused a subcellular 
relocation of pTBK1 from centrosomal/cytosolic to mitochondrial locations. Consistent with 
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its role in mitotic proliferation, pTBK1 was present in mitotic uninfected RGCs and NES 
cells throughout the cytoplasm and enriched at the centrosomes and midbody during 
cytokinesis. In contrast, we found pTBK1 localized to mitochondria in ZIKV infected cells 
and depleted in the cytoplasm and centrosomes. This is in agreement with the reported 
recruitment of TBK1 to the mitochondrial antiviral signaling platform in response to viral 
infection (Belgnaoui et al., 2011; Ning et al., 2014). Taken together, these results suggest a 
cell defense mechanism employed by NES cells and RGCs upon ZIKV infection that may 
result in abnormal mitoses. While mitotic impairment in ZIKV infection has been described 
in previous reports (Garcez et al., 2016; Qian et al., 2016; Tang et al., 2016; Li et al., 2016), 
neither TBK1-associated centrosomal and mitotic defects have been previously described.
Because altered cell cycle dynamics may in some instances cause microcephaly, the removal 
of pTBK1 from the centrosome may explain some of the phenotypes associated with ZIKV 
infection. To test this hypothesis, we inhibited TBK1 by Amlexanox or BX795. Application 
of these inhibitors to NES cells impaired mitosis and induced supernumerary centrosomes. 
Multiple centrosomes and nuclei were also present in ZIKV-infected NES cells and RGCs, 
confirming that pTBK1 plays an important role in mitosis in these cells. Intriguingly, the 
majority of human microcephaly-associated genes encode centrosomal proteins (Diaz and 
Gleeson, 2009; Roberts et al., 2000; Woods, 2004). Moreover, studies in mutant mice and 
humans with mutations in centrosomal genes exhibit deficits including supernumerary 
centrosomes and failed cytokinesis, resulting in severely defective neurogenesis, massive 
apoptosis in the proliferative zones, and microcephaly (Bae et al., 2015; Diaz and Gleeson, 
2009; Roberts et al., 2000; Woods, 2004).
pTBK1 is recruited to mitochondria in response to RNA virus infections, where it serves to 
transduce signals from MAVS protein and activate IRF-3 (Liu et al., 2015). Given that other 
flaviviruses induce RLR-mediated MAVS signaling (Lazear et al., 2013; Suthar et al., 2013), 
it is likely that mitochondrial relocalization of pTBK1 in ZIKV-infected NES cells and 
RGCs occurs via MAVS signaling. Supporting this possibility, treatment with KIN1408, a 
known RLR agonist, phenocopied both the relocalization of pTBK1 and the induction of 
CASP3-mediated cell death in NES cells. These data therefore support the model that ZIKV 
disrupts mitosis in neural stem cells by activating RLRs. Interestingly, another human 
TORCH pathogen, HCMV, caused a similar relocalization of pTBK1 and CASP3-mediated 
cell death. However, DENV, a flavivirus that inhibits RLR/MAVS/pTBK1 signaling 
(Dalrymple, Cimica and Mackow, 2015; He et al., 2016), did not induce pTBK1 
relocalization while still resulting in apoptotic cell death. It is unlikely, however, that the 
mitochondrial localization of pTBK1 alone is sufficient to explain the extensive cell death 
observed in more severe examples of ZIKV-infected fetal brain. The presence of uninfected 
RGCs exhibiting atypical cytomegalic “balloon” morphologies suggests that even uninfected 
neural cells can be non-cell autonomously affected in response to ZIKV infection (Bell et 
al., 1971). Different cell types in the adult brain, including astrocytes, may be infected with 
ZIKV, and nonetheless seem to survive for extended periods of time. In this and earlier 
studies in mouse models of ZIKV infection, neurons maintained normal morphology, despite 
being infected by ZIKV and likely survived for extended period of time. Similarly, we 
observed numerous RGCs and ependymal cells in ZIKV-infected postmortem human fetal 
NCX and spinal cord that exhibited no obvious signs indicative of impending cell death. 
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Crucially, these cells are either slowly dividing as neurogenesis has already ceased or are 
largely postmitotic, which raises the possibility that the process of mitosis, or attempting to 
go through mitosis in the absence of centrosomal pTBK1, may be the central mechanism 
underlying ZIKV-induced depletion of the neural progenitor pool and the subsequent 
microcephalic phenotype. Additionally, ZIKV may not affect neuronal migration even 
though the centrosome is critical for this process (Bae et al., 2015; Diaz and Gleeson, 2009; 
Woods, 2004).
We identified two nucleoside analogs, including the FDA-approved drug Sofosbuvir, that 
inhibit ZIKV infection and cytopathology in NES cells. Further study is warranted to 
examine the efficacy of Sofosbuvir in inhibiting ZIKV in humans and test safety in pregnant 
women. In contrast, the TBK1 inhibitor Amlexanox, which is used clinically (Reilly et al., 
2013), may exacerbate ZIKV-induced cytopathic effects.
Finally, our work may have significant implications concerning the effects of infection, the 
innate immune response, and the development of the CNS. The human CNS is usually 
considered an immunoprivileged organ and is generally protected from pathogens 
circulating in the rest of human body during development, by the placenta (Burton and 
Fowden, 2015; Mor, 2016) and the forming blood-brain and blood-cerebrospinal fluid 
barriers (Marín-Padilla, 2012; Møllgård and Saunders, 1986). However, some pathogens, 
such as ZIKV, possess the ability to cross the placenta and blood-brain barriers and infect the 
brain. Notably, almost all congenital TORCH infections involve some aspect of 
neurodevelopmental defect, including retinopathy, brain calcification and microcephaly 
(Fine and Arndt, 1985; Neu et al., 2015). Considering shared clinical features and the pivotal 
role of TBK1 in the innate immune response to viruses and in autophagic clearance of 
various types of pathogens (Helgason et al., 2013; Thurston et al., 2009), we found that 
HCMV congenital infections may disrupt the development of human CNS through 
overlapping mechanisms that involve altering the subcellular localization and function of 
pTBK1 in human neural stem cells.
Future studies are expected to dissect the role of pTBK1 in innate immune response and the 
exact mechanisms by which centrosomal depletion of pTBK1 is triggered in the context of 
RLRs/MAVS signaling. Furthermore, the functional characterization of downstream effects 
of pTBK1 mitochondrial activation will reveal its role in cell death and potential molecular 
targets in a broad scenario of viral infection.
In summary, our study shows the utility of different in vitro and ex vivo model systems of 
human neural stem cells to study early neurodevelopment and ZIKV infections, reveals 
cellular and molecular mechanisms underlying neurodevelopmental defects associated with 
ZIKV infection and, potentially, other pathogens.
EXPERIMENTAL PROCEDURES
Ethics Statement
This study was conducted using de-identified postmortem human specimens from tissue 
collection at the Department of Neuroscience, Yale School of Medicine and tissue specimens 
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provided by the Human Developmental Biology Resource (www.hdbr.org), and by the 
Laboratory of Developmental Biology at the University of Washington. Appropriate 
informed consent was obtained and all available non-identifying information was recorded 
for each specimen. All work was performed according to NIH guidelines for the acquisition 
and distribution of human tissue for bio-medical research purposes and with approval by the 
Human Investigation Committees and Institutional Ethics Committees of each institute from 
which samples were obtained. Appropriate written informed consent was obtained and all 
available non-identifying information was recorded for each sample. Details of the 
specimens analyzed are provided in the Supplemental Information.
Human NES Cells Derivation
Neuroepithelial stem (NES) cells were derived from dorsal forebrain and spinal cord from 
de-identified prenatal human specimens. Briefly, tissues were dissociated until a single-cell 
suspension was formed. Cells were resuspended and plated into coated dishes. See the 
Supplemental Experimental Procedures for details.
Single-Cell RNA-seq Analysis
Cells were captured using C1 Single-Cell Auto Prep Integrated Fluidic Circuit (Fluidigm). 
Single-cell sequencing libraries were generated according to manufacturer’s protocol. Reads 
were aligned using STAR (v2.4.0). Gene expression was calculated using RSEQTools and 
SAMtools. See the Supplemental Experimental Procedures for details and analysis pipelines.
Ex Vivo Fetal Organotypic Slices Cultures
Cortical walls from four fetal brains were dissected in hibernate solution. Tissue was then 
imbedded in agarose and sectioned. 300 µm slices were transferred to cell culture with 
neuronal medium. See the Supplemental Experimental Procedures for details.
Preparation of Virus Stocks
ZIKV strain FSS 13025 was obtained from the World Reference Center for Emerging 
Viruses and Arboviruses at University of Texas Medical Branch, Galveston. The Brazilian 
ZIKV strain PE243 was recovered from a 19 year-old female in Brazil in late 2015. DENV-2 
strain 16681 was recovered from the cDNA clone pD2/IC-30P. See the Supplemental 
Experimental Procedures for details. Independent stocks of HCMV-GFP were kindly 
supplied by Felicia Goodrum and Scott Terhune.
ZIKV Infection of NES Cells and Fetal Organotypic Brain Slices
For NES cell infections, cells were seeded one day before virus addition. All viral infections 
were performed under the same conditions at an MOI of 0.1 for 2 h followed by three 
washes and addition of fresh NES medium. For fetal organotypic brain slices, viruses were 
added to culture medium. See the Supplemental Experimental Procedures for details.
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Application of Small-Molecule Inhibitors
Amlexanox was applied at 10µM, BX795 at 1 µM, KIN1408 at 10 µM (final concentration). 
Sofosbuvir and 2´C-methyladenosine at the indicated concentrations. See the Supplemental 
Experimental Procedures for details.
BrdU Labeling, Immunostaining and Electron Microscopy
10 µM BrdU was administered 30 min prior to viral infection and then continued until cell 
harvesting. For immunostaining, fixed samples were permeabilized and blocked at room 
temperature, incubated with primary antibodies overnight at 4°C, washed and incubated with 
secondary antibodies. All images were acquired using a fluorescent microscopy or a laser 
scanning confocal microscope. For detailed methods and electron microscopy see the 
Supplemental Experimental Procedures.
RNA Isolation, Droplet Digital PCR and Immunoblotting
Total RNA or proteins were extracted from mock and infected samples as described in 
Supplemental Experimental Procedures.
Statistical Analysis
The presented data are mean ± SD or SEM from three separate experiments. Differences 
between the groups were analyzed using the t-test. Values of all significant correlations are 
given with degree of significance indicated (* p ≤ 0.05, ** p < 0.01, *** p < 0.001). For 
organotypic slice culture, quantification was performed in up to 4 sections that were 
representative of at least 3 slices. Cells were counted as described in the respective figure 
legend. The number of cells with pTBK1 located in centrosomes or mitochondria follows a 
binomial distribution. Fisher’s exact test was performed to compare the control and the 
infected/treated group. Similarly, to test whether infection changed the number of 
centrosomes, the cells were binned by the number of centrosomes (1–5), and Fisher’s exact 
test was performed to compare control with infected/treated cells.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• Derivation of human neocortical and spinal cord neuroepithelial stem 
(NES) cells
• Zika virus (ZIKV) infects NES cells and radial glia, impairing mitosis 
and survival
• ZIKV induces mitochondrial sequestration of centrosomal phospho-
TBK1
• Nucleoside analogs inhibit ZIKV replication, protecting NES cells 
from cell death
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Figure 1. Derivation, Profiling and ZIKV infection of NES Cells
(A) Schematic of experimental procedure. NES cells were derived from human developing 
neocortex (NCX) or spinal cord (SC). Donor-matched brain tissues and NCX-NES cells 
were subjected to single-cell RNA-seq. SC-NES cells are described in Figure S1.
(B) NCX-NES cells form rosette structures after 24h in culture. Scale bars, 50µm.
(C–E) NCX-NES cells are positive for nestin (NES), SOX2 (99.4±0.8%, n=973), SOX1 
(87.8±1.9%, n=1265), CTNNB1 and FOXG1 (96.5±1.1%, n=1277). Scale bars, 50µm.
(F) Violin plots showing expression of cell type-specific marker genes in NCX-NES cells 
and donor-matched NCX tissue single cells. pan-NSC, pan-neural stem cell; vRGC, 
ventricular radial glia cell; oRGC outer radial glia cell; IPC, intermediate progenitor cell; 
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Intern., interneuron; Ast., astrocyte; Olig., oligodendrocyte; Micro., microglia. Y-axis, log2 
transformed RPKM.
(G) As in F, violin plots of ventral forebrain marker genes in NCX-NES and donor-matched 
NCX single cells.
(H and I) t-SNE plots of all NES cell lines and brain single cells colored by origin of the 
cells (H) or by cell type clusters identified with SNN-Cliq clustering algorithm (I).
(J and K) Electron microscopy images of mock (J) or ZIKV-infected (K) NCX-NES cells. 
Nucleus (N) appears to be normal (J’) and cytoplasm is clear of ZIKV viral particle (J”) in 
mock condition.
Nuclear fragmentation is evident in ZIKV-infected condition. Viral particles are evident 
around nuclear envelope (red arrows in K’, K”). Scale bars, 1µm.
See also Figures S1-S4.
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Figure 2. ZIKV Infects RGCs and Disrupts RG Scaffolding of Fetal Neocortical Organotypic 
Slices
(A) Schematic representation of the experimental procedure.
(B) Schematic illustration of the early fetal neocortex (NCX). Vimentin (VIM) and DAPI 
immunostaining of pre-infection slices shows a normal architecture of neocortical wall. 
Higher magnification of CP and VZ reveals the radial organization of VIM+ RG fibers 
reaching the pial surface. MZ, marginal zone; CP, cortical plate; IZ/SP, intermediate zone/
subplate; SVZ, subventricular zone; VZ, ventricular zone; PN, projection neuron; oRGC, 
outer radial glia cell; IPC, intermediate progenitor cell; vRGC, ventricular radial glia cell.
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(C) Organotypic brain slices show ZIKV infection in RGCs at 1.5 days post infection (DPI), 
80.6±0.6% of the infected cells localized in VZ/SVZ, 19.4±4% in the IZ/SP and none in CP 
(total number of infected cells=20). VZ/SVZ are significantly more infected than CP (paired 
t-test p<0.05). The slices maintain a normal structure, with radial glial fibers reaching the 
pial surface and a normal orientation in VZ and SVZ.
(D and E) Non-infected neocortical slices show normal morphology and RG scaffold at both 
DPI 3.5 (D) and 6.5 (E).
(F and G) ZIKV-infected slices show severe defects in RG scaffolding at DPI 3.5 (F) and 6.5 
(G). Most of the infected cells are located in VZ/SVZ and IZ/SP regions (73.3±28.7% at 
DPI 3.5; 89.3±3.4% at DPI 6.5) with fewer CP neurons showing infection (26.7±28.7% at 
DPI 3.5 and 10.7±3.4% DPI at DPI 6.5, respectively; total number of infected cells=456 at 
DPI 3.5 and 1315 at DPI 6.5). At DPI 6.5, CP was significantly less infected than the other 
zones of the NCX (paired two-tailed t-test p<0.01). Regions with high numbers of infected 
cells, in between arrowheads, show a more pronounced defect in radial orientation of RG 
fibers. Furthermore, it is possible to observe balloon-like cells that express VIM.
Arrowheads indicate cells that are infected with ZIKV, immunopositive for NS1. Arrows 
show RG fibers. Scale bars, 50µm. See also Figure S5.
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Figure 3. Neocortical RGCs Express ZIKV Epitopes in a Late Fetal Microcephalic ZIKV-
Infected Brain
(A) Tissue section of a 30 pcw microcephalic fetus from a ZIKV-infected mother. Higher 
magnification shows protrusions (asterisk) in ventricular zone (A’). LV, Lateral ventricle; 
STR, striatum; NCX, neocortex.
(B and C) Immunostaining of an uninfected brain show no NS1+ cells in NCX (B) and no 
ZIKVE+ cells in the NCX VZ/SVZ (C).
(D and E) In the infected brain, most of the infected cells (arrowhead) are in VZ/SVZ 
(64.2% of the total cells) (D). Only 1.2% of CP cells are ZIKV-infected (D) (number of total 
analyzed cells in the single microcephalic fetal human brain reported=1050). Filled 
arrowhead depicts red blood cells (D).
(F and G) Immunostaining for vimentin (VIM) in both VZ/SVZ and NCX shows a normal 
radial orientation of basal processes of RGCs (arrow, F and G).
(H) Upper layers of the NCX show an impaired organization and lower nuclei density 
compared to uninfected control NCX. Arrow depicts a defective radial process.
(I) Periventricular region showing dysplastic intraventricular protrusions with lower density 
of RGCs (asterisk) and disorganized RG morphology (arrow) and processes.
(J) NCX of the infected brain displays disorganized arrangement of dysplastic TUBB3+ 
neurons.
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(K) Central canal of the spinal cord immunostained for ZIKVE. Filled arrowhead shows 
positive red blood cells. Ependymal cells are not labeled.
(L) Co-labelling of nestin (NES) and aCASP3 shows positive cells (arrowheads) in the 
infected brain with no radial fibers.
(M) ZIKVE and aCASP3 staining shows positive cells (arrowheads) in the infected NCX. 
Filled arrowhead depicts red blood cells.
Scale bars, 50µm.
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Figure 4. NES Cells and RGCs Express Candidate ZIKV Entry Receptors AXL and TYRO3
(A and B) Violin plots of candidate entry factor gene expression distributions in NCX-NES 
and donor-matched NCX single cells (A) or adult NCX (B). Y-axis, log2 transformed RPKM 
(A) or log2 transformed RPM (B). Proj. neuro., projection neuron; Interneuro., interneuron; 
Oligo., oligodendrocyte; Endo. cells, endothelial cells.
(C and D) Expression trajectories of AXL (C) and TYRO3 (D) during human 
neurodevelopment in different brain regions. Y-axis represents gene expression quantified by 
log2 transformed signal intensities and the X-axis represents the developmental ages 
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quantified by the log10 transformed post-conceptional days. The dash vertical lines indicate 
the 15 developmental periods as defined by Kang et al. (2011). The trajectory curves are 
smoothed by lowess function. The shading areas represent mean±SEM. NCX, neocortex; 
HIP, hippocampus; AMY, amygdala; STR, striatum; MD, mediodorsal nucleus of the 
thalamus; CBC, cerebellar cortex.
(E, F) Immunostaining showing that NES cells co-express AXL and VIM.
(G) Immunostaining of AXL and VIM in a 16 pcw fetal NCX shows that AXL is 
predominantly low expressed in the CP (G’), where it is detected mainly in blood vessels. 
Contrarily, higher expression of AXL is detected in the VZ/SVZ (G”).
(H) Fetal organotypic slices infected with ZIKV are NS1+ in VZ/SVZ RGCs that are also 
AXL+. Arrows point to AXL+ cells. Arrowheads indicate the presence of ZIKV infection. 
Asterisks indicate signal blood vessels.
(I) Expression of AXL in the adult NCX is restricted mainly to the astrocyte ribbon, which is 
also strongly labeled by GFAP, endothelial cells and some astrocyte processes in CP.
MZ, marginal zone; CP, cortical plate; IZ, intermediate zone; SP, subplate; SVZ, 
subventricular zone; VZ, ventricular zone; LV, lateral ventricle; EL, ependymal layer. Scale 
bars, 50µm See also Figure S6.
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Figure 5. Centrosomal Depletion and Mitochondrial Sequestration of pTBK1 in ZIKV-Infected 
NES cells and RGCs
(A) Violin plots of TBK1 gene expression level in single cells from NCX-NES cells, fetal 
neocortical slices and adult NCX. Y-axis, log2 transformed RPKM for NCX-NES cells and 
fetal NCX cells, or log2 transformed RPM for adult NCX single cells. (B) Digital droplet 
PCR (n=3 biological replicates) shows higher TBK1 expression in NCX-NES cells 
compared to organotypic slices. No differences in TBK1 levels between ZIKV (Cambodian 
or Brazilian strains, ZIKVC and ZIKVB, respectively) infected and Mock conditions, in 
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NCX-NES cells and fetal neocortical organotypic slices at DPI 3.5 (as well as at DPI 1.5, 
not shown).
(C) Western blot of TBK1 and pTBK1 in VZ/SVZ and CP.
(D) Immunostaining for pTBK1 and phosphorylated VIM (pVIM) in NES cells, labeling 
centrosome and midbody (arrows). pTBK1 and PAX6 are expressed in fetal NCX. pTBK1 
and pVIM can be detected in NES cells that are dividing. PAX6 is co-expressed with pTBK1 
in VZ and SVZ of fetal NCX and labels cells that are in mitosis. Neither pTBK1 nor PAX6 
are detected in CP.
(E – H) NES cells immunostaining shows that pTBK1 is colocalized with the centrosome 
marker TUBG (G), but not with the mitochondria marker ATP5A1 (E), in non-infected cells. 
Contrarily, in ZIKV-infected NES cells, pTBK1 is relocalized to mitochondria, as can be 
observed by co-staining of pTBK1 with ATP5A1 (F), but not with TUBG (H). Infected cells 
have an abnormal number of centrosomes, as pointed by arrows. Arrowheads indicate 
mitochondrial staining and asterisks multiple nuclei.
(I and J) Electron microscopy confirms the subcellular localization of pTBK1 in the 
centrosome (red arrows) and cytoplasm (asterisks) of non-infected cells (I). In infected cells, 
the signal is detected mainly in mitochondria (J), as pointed by arrowheads. ZIKV particles 
are also visible in the cytoplasm of infected cells (green arrows).
(K – N) Immunostaining of pTBK1 in neocortical slices shows its localization in the 
centrosomes and colocalization with TUBG, but not with ATP5A1 in non-infected cells (K 
and M). In infected cells pTBK1 is present in mitochondria (L). Infected cells in mitosis also 
show an abnormal number of centrosomes (N). In some infected cells with multiple 
centrosomes pTBK1 and TUBG colocalize.
(O) Bar plot indicating the percentage of pTBK1 localized in centrosomes or mitochondria 
in Mock or ZIKV conditions. pTBK1 is mainly localized in centrosomes in Mock or 
mitochondria in ZIKV-infected cells (number of pTBK1+ NES cells=23 out of 1364 total 
cells for Mock and 56 out of 673 total cells for ZIKV; number of pTBK1+ brain slice 
cells=50 from 2 sections for Mock and 31 from 4 sections for ZIKV). Data are presented as 
mean±SEM. Fisher’s exact test *** p<0.001.
(P) Jitter plot showing the number of centrosomes in pTBK1+ cells, in both NES cells and 
slice cultures. While in non-infected mitotic cells the number of centrosomes is 
predominantly 2, in infected cells it ranges from 1 to 5 (number of pTBK1+ NES cells=40 
for Mock and 80 for ZIKV condition; number of pTBK1+ brain slice cells=76 from 2 
sections for Mock and 21 from 4 sections for ZIKV). Fisher’s exact test ** p<0.01, *** 
p<0.001.
(Q) Bar plot of mitochondrial area and mitochondrial density in non-infected and infected 
NES cells. There is a statistical significant increase in the mitochondrial area between Mock 
and ZIKV conditions. No difference is present between Mock and ZIKV for mitochondrial 
density. Two-tailed t-test * p≤0.05.
(R) Representative immunofluorescence staining of vehicle-, Amlexanox- and BX795-
treated NCX-NES cells shows supernumerary centrosomes induced by TBK1 inhibition.
(S) Quantification of pTBK1+ mitotic NCX-NES cells with or without TBK1 inhibition. 
Scale bars, 20µm (D–N) and 50µm (R). Two-tailed t-test ** p<0.01, *** p<0.001. See also 
Figure S6 and S7.
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Figure 6. Relocalization of pTBK1 by Other Viruses and Innate Immune Stimulation in NES 
Cells
(A) Both the flavivirus Dengue-2 virus (DENV) and human Cytomegalovirus (HCMV) 
infect NCX-NES cells and induce aCASP3-mediated cell death, but only HCMV can induce 
relocalization of pTBK1 at DPI 3.5.
(B) Bar plot indicating the percentage of pTBK1 that was localized in centrosomes or 
mitochondria in Mock, DENV, or HCMV conditions (number of pTBK1+ cells=10 out of 
1074 total cells for mock; 7 out of 1194 cells for DENV and 392 out of 441 cells for HCMV, 
respectively). Fisher’s exact test *** p<0.001.
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(C) Bar plot of the percentage of aCASP3+ cells in Mock and DENV- or HCMV-infected 
NCX-NES cells at DPI 3.5 (number of aCASP3+ cells=1 out of 1041 total cells for mock; 21 
out of 842 cells for DENV and 10 out of 472 cells for HCMV). Two-tailed t-test * p<0.05, 
** p<0.01.
(D) Treatment with the agonist of RIG-I-like receptors KIN1408 induces relocalization of 
pTBK1 from centrosomes to mitochondria and increased aCASP3-mediated cell death.
(E) Bar plot indicating the percentage of pTBK1 that was localized in centrosomes or 
mitochondria in vehicle- or KIN1408-treated NES cells after 2 day-treatment (number of 
pTBK1+ cells=10 out of 1074 total cells for vehicle and 19 out of 934 cells for KIN1408). 
Fisher’s exact test *** p<0.001.
(F) Bar plot indicating the percentage of aCASP3+ cells in vehicle- or KIN1408-treated NES 
cells (number of aCASP3+ cells=3 out of 1236 total cells for vehicle, and 23 out of 546 cells 
for KIN1408). Two-tailed t-test ** p<0.01.
Scale bars, 50µm.
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Figure 7. Nucleoside and Nucleotide Analogs Inhibit ZIKV Replication and Protect NES Cells
(A) Representative pictures showing 2´-C-methyladenosine and Sofosbuvir treatment on 
ZIKV-infected NES cells at DPI 3.5. At different concentrations, both drugs show a potent 
anti-ZIKV activity, as demonstrated by NS1 staining. pTBK1 localization is centrosomal in 
infected, drug-treated cells. aCASP3 staining shows apoptotic cell death rate in the different 
conditions.
(B) Bar plot indicating the percentage of NS1+ cells in ZIKV-infected NES cells after 
vehicle- or drug-treatment at DPI 3.5 [number of NS1+ cells=2961 out of 3501 total cells for 
vehicle; 7 out of 2118 total cells for 2´-C-methyladenosine (20µM); 2 out of 1959 total cells 
Onorati et al. Page 33
Cell Rep. Author manuscript; available in PMC 2017 September 06.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
for 2´-C-methyladenosine (40µM), 136 out of 2248 total cells for Sofosbuvir (20µM ) and 25 
out of 2099 total cells for Sofosbuvir (100µM)]. Two-tailed t-test * p<0.05, *** p<0.001. 
n.s., not significant.
(C) Bar plot of the percentage of aCASP3+ cells in ZIKV-infected NES cells after vehicle- 
or drug-treatment at DPI 3.5 [number of aCASP3+ cells=27 out of 1403 total cells for 
vehicle; 14 out of 955 total cells for 2´-C-methyladenosine (20µM); 24 out of 502 total cells 
for 2´-C-methyladenosine (40µM); 5 out of 657 total cells for Sofosbuvir (20µM ) and 4 out 
of 727 total cells for Sofosbuvir (100mµM)].Two-tailed t-test * p<0.05, ** p<0.01. n.s., not 
significant.
(D) Bar plot indicating the percentage of pTBK1 that was localized in centrosomes or 
mitochondria in ZIKV-infected NES cells after vehicle- or drug-treatment at DPI 3.5 
(number of pTBK1+ cells=32 out of 2098 total cells for vehicle; 5 out of 1163 total cells for 
2´-C-methyladenosine (20µM); 4 out of 1457 cells for 2´-C-methyladenosine (40µM); 13 out 
of 1591 cells for Sofosbuvir (20µM) and 17 out of 1373 total cells for Sofosbuvir (100µM). 
Fisher’s exact test *** p<0.001. Scale bars, 20µm.
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